Opus Genetics Inc. (IRD) at a glance

Opus Genetics Inc. (IRD) is a small-cap Healthcare company. It trades at $3.7, with a 0% profit margin and revenue decline of 50.6%. It does not pay a dividend. Vestovix scores it 47/100 overall. Its strongest dimension is Safety (90/100) and its weakest is Growth (11/100). It is a relatively defensive holding with below-market volatility.

Price

$3.70

Market cap

$333.6M

P/E ratio

n/a

Dividend yield

None

Beta

0.55

52-week range

$1.17 to $5.81